Antenatal Corticosteroids and Respiratory Distresses Outcome in Preterm Neonates

Background: The value of antenatal corticosteroid regimen in lessening respiratory distress risk in preterm neonates has been well known, and accordingly, antenatal corticosteroid therapy was recommended for any pregnant woman likely to deliver between 24 and 34 weeks of gestation. Therefore, this s...

Full description

Bibliographic Details
Main Authors: Fatma Mohamed, Badr El Din Mesbah, Abdelmoneim Khashana
Format: Article
Language:English
Published: Mashhad University of Medical Sciences 2021-04-01
Series:Iranian Journal of Neonatology
Subjects:
Online Access:https://ijn.mums.ac.ir/article_17383_350bb7e5b87fc0922c4dbf6ccb086c97.pdf
_version_ 1818356468758347776
author Fatma Mohamed
Badr El Din Mesbah
Abdelmoneim Khashana
author_facet Fatma Mohamed
Badr El Din Mesbah
Abdelmoneim Khashana
author_sort Fatma Mohamed
collection DOAJ
description Background: The value of antenatal corticosteroid regimen in lessening respiratory distress risk in preterm neonates has been well known, and accordingly, antenatal corticosteroid therapy was recommended for any pregnant woman likely to deliver between 24 and 34 weeks of gestation. Therefore, this study aimed to assess the association between the administration of antenatal corticosteroids within the ideal interval of one week before birth and the outcomes of preterm neonates. Methods: This prospective cohort study included 80 preterm neonates admitted to the neonatal intensive care unit with gestational age from 32 to 37 complete weeks at Suez Canal University Hospitals, Ismailia, Egypt. The newborns were then divided into groups A (did not receive antenatal corticosteroids; n=40) and B (received antenatal corticosteroids; n=40). Results: Severe respiratory distress syndrome was significantly less frequent in group B  (P<0.05) with lower levels of need for oxygen supplementation (P<0.05). Conclusion: Neonates who received antenatal corticosteroids developed less severe respiratory distress, compared to neonates who did not receive this medication. The results favored the use of antenatal corticosteroids to prevent respiratory distress when administrated within the ideal interval of one week before birth.
first_indexed 2024-12-13T19:57:42Z
format Article
id doaj.art-5bed0a0d725e45efb56b2376f2d9a61b
institution Directory Open Access Journal
issn 2251-7510
2322-2158
language English
last_indexed 2024-12-13T19:57:42Z
publishDate 2021-04-01
publisher Mashhad University of Medical Sciences
record_format Article
series Iranian Journal of Neonatology
spelling doaj.art-5bed0a0d725e45efb56b2376f2d9a61b2022-12-21T23:33:16ZengMashhad University of Medical SciencesIranian Journal of Neonatology2251-75102322-21582021-04-01122404510.22038/ijn.2021.49556.186517383Antenatal Corticosteroids and Respiratory Distresses Outcome in Preterm NeonatesFatma Mohamed0Badr El Din Mesbah1Abdelmoneim Khashana2Bir El Abd Hospital, North Sini, EgyptFaculty of Medicine, Suez Canal University, Ismailia, EgyptFaculty of Medicine, Suez Canal University, Ismailia, EgyptBackground: The value of antenatal corticosteroid regimen in lessening respiratory distress risk in preterm neonates has been well known, and accordingly, antenatal corticosteroid therapy was recommended for any pregnant woman likely to deliver between 24 and 34 weeks of gestation. Therefore, this study aimed to assess the association between the administration of antenatal corticosteroids within the ideal interval of one week before birth and the outcomes of preterm neonates. Methods: This prospective cohort study included 80 preterm neonates admitted to the neonatal intensive care unit with gestational age from 32 to 37 complete weeks at Suez Canal University Hospitals, Ismailia, Egypt. The newborns were then divided into groups A (did not receive antenatal corticosteroids; n=40) and B (received antenatal corticosteroids; n=40). Results: Severe respiratory distress syndrome was significantly less frequent in group B  (P<0.05) with lower levels of need for oxygen supplementation (P<0.05). Conclusion: Neonates who received antenatal corticosteroids developed less severe respiratory distress, compared to neonates who did not receive this medication. The results favored the use of antenatal corticosteroids to prevent respiratory distress when administrated within the ideal interval of one week before birth.https://ijn.mums.ac.ir/article_17383_350bb7e5b87fc0922c4dbf6ccb086c97.pdfantenatalcorticosteroidspretermrespiratory distress syndrome (rds)
spellingShingle Fatma Mohamed
Badr El Din Mesbah
Abdelmoneim Khashana
Antenatal Corticosteroids and Respiratory Distresses Outcome in Preterm Neonates
Iranian Journal of Neonatology
antenatal
corticosteroids
preterm
respiratory distress syndrome (rds)
title Antenatal Corticosteroids and Respiratory Distresses Outcome in Preterm Neonates
title_full Antenatal Corticosteroids and Respiratory Distresses Outcome in Preterm Neonates
title_fullStr Antenatal Corticosteroids and Respiratory Distresses Outcome in Preterm Neonates
title_full_unstemmed Antenatal Corticosteroids and Respiratory Distresses Outcome in Preterm Neonates
title_short Antenatal Corticosteroids and Respiratory Distresses Outcome in Preterm Neonates
title_sort antenatal corticosteroids and respiratory distresses outcome in preterm neonates
topic antenatal
corticosteroids
preterm
respiratory distress syndrome (rds)
url https://ijn.mums.ac.ir/article_17383_350bb7e5b87fc0922c4dbf6ccb086c97.pdf
work_keys_str_mv AT fatmamohamed antenatalcorticosteroidsandrespiratorydistressesoutcomeinpretermneonates
AT badreldinmesbah antenatalcorticosteroidsandrespiratorydistressesoutcomeinpretermneonates
AT abdelmoneimkhashana antenatalcorticosteroidsandrespiratorydistressesoutcomeinpretermneonates